Pricing

Log inSign up

Alnylam Pharmaceuticals

1,426 people · 0 jobs
‌

Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.

Industries

Pharmaceutical

Headquarters

Cambridge, United States

Employees

1,001-5,000

Links

Org chart

Yvonne Greenstreet
CEO
Collapse
Pushkal Garg
Chief Research & Development Officer
Jeff Poulton
CFO
Vasant Jadhav
Chief Technology Officer
Tolga Tanguler
CCO
Kevin Fitzgerald
Chief Scientific Officer
Timothy Maines
Chief Technical Operations & Quality Officer
Christine Lindenboom
Chief Corporate Communications Officer
Robert Hesslein
Chief Legal Officer & Corporate Secretary
MT
Mike Tirozzi
Svp, Chief Information And Data Officer
Melissa Mclaughlin
Chief Human Resources Officer
Sally Collins
Vice President, Head Of International, Rare Disease
TS
Tara Smith
Vp, Chief Of Staff To The CEO
Bryan Supran
Chief Legal Officer
JR
James Reindel
Executive Director
Yutaka Okada
President And Representative Director, Alnylam Japan KK
John Gansner
Executive Director

Board & advisors

AS
Amy W. Schulman
Chair
Colleen Reitan
Director
David E.i. Pyott
Board Member
DA
Dennis A. Ausiello
Director
MH
Margaret A. Hamburg
Director
MB
Michael W. Bonney
Director
OB
Olivier Brandicourt
Director
ES
Elliott Sigal
Director
PK
Peter N. Kellogg
Director
CB
Carolyn Bertozzi
Director

Similar companies

West Pharmaceutical Services

9 followers

Curia Global

7 followers

Agiliti

7 followers

Bristol-Myers Squibb

274 followers

NYU Langone Health

34 followers

Tilray

19 followers

Dechra Pharmaceuticals

9 followers

AbbVie

293 followers

Navitus Health

5 followers

Cambrex

4 followers

CONMED

2 followers

Explore companies